Open Collections

Tan, Ju Ann; Dehghan, Natasha; Chen, Wenjia; Xie, Hui; Esdaile, John; Aviña-Zubieta, J. Antonio

Objective To determine the magnitude of all-cause mortality risk in patients with ANCA-associated vasculitis (AAV) compared with the general population through a meta-analysis of observational studies. Methods We searched Medline and EMBase databases from their inception to April 2015. Observational studies that met the following criteria were assessed by two researchers: 1) clearly defined AAV identified by either the American College of Rheumatology 1990 classification criteria or the 2012 Chapel Hill Consensus Conference disease definitions, and 2) reported standardized mortality ratios (SMR) and 95% confidence intervals (95% CI). We calculated weighted-pooled summary estimates of SMRs (meta-SMRs) for all cause mortality using random effects model, tested for publication bias and heterogeneity. Results Ten studies met the inclusion criteria, comprising 3,338 AAV patients enrolled from 1966-2009 and a total of 1,091 observed deaths. Overall, we found a 2.7-fold increased risk of death in AAV patients when compared to the general population (meta-SMR 2.71 [95% CI 2.26-3.24]). Analysis on studies that included only granulomatosis with polyangiitis (GPA) cases also indicated a similar mortality risk (meta-SMR 2.63, [95% CI 2.02-3.43]). There was no significant publication bias or small-study effect. Subgroup analyses showed that mortality risks were higher in older cohorts with a trend towards improvement over time (i.e., those with their midpoint of enrolment periods that were between 1980-1993 and 1994-1999, versus 2000-2005). Conclusion Published data indicate there is a 2.7-fold increase in mortality amongst AAV patients compared to the general population.

Postprint

eng

Vancouver : University of British Columbia Library

10.14288/1.0388268

Medicine, Faculty of; Pharmaceutical Sciences, Faculty of; Non UBC; Medicine, Department of

10.1136/annrheumdis-2016-210942

Faculty

DSpace